- Home
- KPRX vs MKZR Comparison
KPRX vs MKZR Comparison
Compare KPRX & MKZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KPRX
- MKZR
- Stock Information
- Founded
- KPRX 1998
- MKZR 2012
- Country
- KPRX United States
- MKZR United States
- Employees
- KPRX N/A
- MKZR N/A
- Industry
- KPRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- MKZR
- Sector
- KPRX Health Care
- MKZR
- Exchange
- KPRX Nasdaq
- MKZR Nasdaq
- Market Cap
- KPRX 8.6M
- MKZR 10.3M
- IPO Year
- KPRX N/A
- MKZR N/A
- Fundamental
- Price
- KPRX $2.99
- MKZR $0.63
- Analyst Decision
- KPRX Strong Buy
- MKZR
- Analyst Count
- KPRX 1
- MKZR 0
- Target Price
- KPRX $10.00
- MKZR N/A
- AVG Volume (30 Days)
- KPRX 62.4K
- MKZR 536.4K
- Earning Date
- KPRX 08-08-2025
- MKZR 08-11-2025
- Dividend Yield
- KPRX N/A
- MKZR 55.53%
- EPS Growth
- KPRX N/A
- MKZR N/A
- EPS
- KPRX N/A
- MKZR N/A
- Revenue
- KPRX $20,000.00
- MKZR $23,037,348.00
- Revenue This Year
- KPRX N/A
- MKZR N/A
- Revenue Next Year
- KPRX N/A
- MKZR N/A
- P/E Ratio
- KPRX N/A
- MKZR N/A
- Revenue Growth
- KPRX N/A
- MKZR 52.64
- 52 Week Low
- KPRX $2.51
- MKZR $0.60
- 52 Week High
- KPRX $4.80
- MKZR $5.50
- Technical
- Relative Strength Index (RSI)
- KPRX 47.28
- MKZR N/A
- Support Level
- KPRX $2.96
- MKZR N/A
- Resistance Level
- KPRX $3.29
- MKZR N/A
- Average True Range (ATR)
- KPRX 0.15
- MKZR 0.00
- MACD
- KPRX 0.01
- MKZR 0.00
- Stochastic Oscillator
- KPRX 38.78
- MKZR 0.00
About KPRX Kiora Pharmaceuticals Inc.
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.
About MKZR MacKenzie Realty Capital Inc.
Mackenzie Realty Capital Inc is a company which is a Real estate investment trust (REIT). The company has one reportable segment, income-producing real estate properties which consists of activities related to investing in real estate.